Headlines

(Image: Getty/Wavebreakmedia)

Q&A

Nemaura to debut 48-hour transdermal pain patch

By Ben Hargreaves

Ahead of the CPhI Worldwide in Madrid next week, Nemaura announced that it would be showcasing its newly developed 48-hour diclofenac transdermal patch and would be linking up with an unnamed global pharma company to develop three new products.